SHHPF (SHHPF) Stock Price & Analysis
SHHPF (SHHPF) fell 25.24% to USD 12.62 as of June 10, 2026 at 02:31 UTC, according to Nexqual real-time market data.
SHHPF last closed at USD 16.88; the session ranged USD 12.62–12.62 on volume of 2 shares. Market capitalization is $1.16B, with a 52-week range of USD 12.62–16.88 (PNK). Source: Nexqual, June 10, 2026 at 02:31 UTC.
Key Statistics (as of June 10, 2026 at 02:31 UTC)
| Price | USD 12.62 |
|---|---|
| Change | ▼ 25.24% (down) |
| Previous Close | USD 16.88 |
| Open | USD 12.62 |
| Day Range | USD 12.62 – 12.62 |
| 52-Week Range | USD 12.62 – 16.88 |
| Volume | 2 shares |
| Market Cap | $1.16B |
| Exchange | PNK |
Technical Analysis (SHHPF)
Nexqual's technical model rates SHHPF "NEUTRAL" based on 4 bullish and 3 bearish signals across 124 daily candles, as of June 10, 2026 at 02:31 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 16.88) |
| MACD | 0 (positive) |
Analyst Ratings (SHHPF)
Wall Street analysts rate SHHPF "None", per Nexqual as of June 10, 2026 at 02:31 UTC.
| Consensus Rating | None |
|---|
Earnings (SHHPF)
| Next Earnings Date | 2026-08-07 |
|---|---|
| Revenue Estimate | $168.05B |
Source: Nexqual, June 10, 2026 at 02:31 UTC.
Financials & Fundamentals (SHHPF)
| Total Revenue | $718.16B |
|---|---|
| Revenue Growth (YoY) | +5.30% |
| Gross Margin | +9.29% |
| Operating Margin | +5.11% |
| Profit Margin | +1.86% |
| ROE | +8.92% |
| Debt / Equity | 19.92 |
| Current Ratio | 1.38 |
| Total Cash | $80.57B |
| Total Debt | $30.37B |
| Free Cash Flow | $19.25B |
Source: Nexqual, June 10, 2026 at 02:31 UTC.
Financial Health Score (SHHPF)
Nexqual rates SHHPF's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:31 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 9%, operating 5% |
| Balance Sheet | Strong — $80.6B cash vs $30.4B debt, net cash position |
| Cash Flow | Mixed — FCF $19.3B, slim 2.7% margin |
| Efficiency | Mixed — ROE 9%, ROA 4.0% |
Ownership (SHHPF)
| Insider Ownership | +20.31% |
|---|---|
| Institutional Ownership | +46.79% |
| Shares Outstanding | 92.02M |
| Float | 76.13M |
Source: Nexqual, June 10, 2026 at 02:31 UTC.
Leadership (SHHPF)
SHHPF is led by Futoshi Ohashi (age 61), President, GM of Corporate Planning Dept and Efficiency Planning Headquarters & Director, per Nexqual as of June 10, 2026 at 02:31 UTC.
| President, GM of Corporate Planning Dept and Efficiency Planning Headquarters & Director | Futoshi Ohashi (age 61) |
|---|---|
| Vice Chairman & GM of the TPP Business Unit | Hirotaka Ogawa (age 67) |
| Vice Chairman & GM of MSP Business Division | Kenzo Konishi (age 68) |
| GM of Administration Headquarters & Director | Yoshio Yasuda (age 65) |
Major Backers & Investors (SHHPF)
Notable institutional backers of SHHPF include Fidelity, American Century ETF Trust-Avantis International Small Cap Value ETF, HARTFORD MUTUAL FUNDS INC/CT-The Hartford International Value Fund, according to Nexqual as of June 10, 2026 at 02:31 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 4.34% |
| American Century ETF Trust-Avantis International Small Cap Value ETF | 1.32% |
| HARTFORD MUTUAL FUNDS INC/CT-The Hartford International Value Fund | 0.89% |
| Bridge Builder Trust-Bridge Builder International Equity Fund | 0.59% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Columbia Threadneedle | 2.32% |
| Vanguard Group | 1.71% |
| BlackRock | 0.66% |
Source: Nexqual, June 10, 2026 at 02:31 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CMOPF | Cosmo Pharmaceuticals NV | USD 92.12 | ▲ 1.08% |
| FRRFF | 4imprint Group Plc | USD 50 | ▲ 0% |
| KSANF | Kansai Paint Co., Ltd. | USD 17.5 | ▲ 0% |
| YPHDF | YPSOMED HOLDING AG | USD 367.87 | ▲ 3.65% |
| KPTCY | KANSAI PAINT CO LTD SPON ADS EA | USD 7.19 | ▼ 10.35% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:31 UTC. This page is informational and not investment advice.